Published in Invest Ophthalmol Vis Sci on December 13, 2013
Study of Dark Adaptation in Age-Related Macular Degeneration | NCT01352975
The Project MACULA Retinal Pigment Epithelium Grading System for Histology and Optical Coherence Tomography in Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci (2015) 1.05
Fully automated detection of diabetic macular edema and dry age-related macular degeneration from optical coherence tomography images. Biomed Opt Express (2014) 0.99
Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease. Neural Regen Res (2015) 0.94
New Insights for Oxidative Stress and Diabetes Mellitus. Oxid Med Cell Longev (2015) 0.94
The generation of induced pluripotent stem cells for macular degeneration as a drug screening platform: identification of curcumin as a protective agent for retinal pigment epithelial cells against oxidative stress. Front Aging Neurosci (2014) 0.92
Cholesterol-mediated activation of acid sphingomyelinase disrupts autophagy in the retinal pigment epithelium. Mol Biol Cell (2014) 0.88
ROCK Inhibition Extends Passage of Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium. Stem Cells Transl Med (2014) 0.88
Expression of human complement factor H prevents age-related macular degeneration-like retina damage and kidney abnormalities in aged Cfh knockout mice. Am J Pathol (2014) 0.85
MiR-9 regulates the post-transcriptional level of VEGF165a by targeting SRPK-1 in ARPE-19 cells. Graefes Arch Clin Exp Ophthalmol (2014) 0.84
Polarized human embryonic stem cell-derived retinal pigment epithelial cell monolayers have higher resistance to oxidative stress-induced cell death than nonpolarized cultures. Stem Cells Transl Med (2014) 0.83
FoxO proteins in the nervous system. Anal Cell Pathol (Amst) (2015) 0.83
4-Acetoxyphenol Prevents RPE Oxidative Stress-Induced Necrosis by Functioning as an NRF2 Stabilizer. Invest Ophthalmol Vis Sci (2015) 0.82
N-Acetylcysteine Amide Protects Against Oxidative Stress-Induced Microparticle Release From Human Retinal Pigment Epithelial Cells. Invest Ophthalmol Vis Sci (2016) 0.82
Clearance of autophagy-associated dying retinal pigment epithelial cells - a possible source for inflammation in age-related macular degeneration. Cell Death Dis (2016) 0.81
Exposure to the complement C5b-9 complex sensitizes 661W photoreceptor cells to both apoptosis and necroptosis. Apoptosis (2015) 0.81
Recent developments in the management of dry age-related macular degeneration. Clin Ophthalmol (2015) 0.81
Programming apoptosis and autophagy with novel approaches for diabetes mellitus. Curr Neurovasc Res (2015) 0.81
Segmentation Based Sparse Reconstruction of Optical Coherence Tomography Images. IEEE Trans Med Imaging (2016) 0.81
A comparison of some organizational characteristics of the mouse central retina and the human macula. PLoS One (2015) 0.80
Microtubule motors transport phagosomes in the RPE, and lack of KLC1 leads to AMD-like pathogenesis. J Cell Biol (2015) 0.78
PGC-1α Induces Human RPE Oxidative Metabolism and Antioxidant Capacity. Invest Ophthalmol Vis Sci (2016) 0.78
Targeting MAPK Signaling in Age-Related Macular Degeneration. Ophthalmol Eye Dis (2016) 0.77
Identification of functional networks associated with cell death in the retina of OXYS rats during the development of retinopathy. Cell Cycle (2015) 0.77
Regeneration in the nervous system with erythropoietin. Front Biosci (Landmark Ed) (2016) 0.76
Spermidine Oxidation-Mediated Degeneration of Retinal Pigment Epithelium in Rats. Oxid Med Cell Longev (2017) 0.75
ROCK Inhibition Promotes Attachment, Proliferation, and Wound Closure in Human Embryonic Stem Cell-Derived Retinal Pigmented Epithelium. Transl Vis Sci Technol (2016) 0.75
Transfer learning based classification of optical coherence tomography images with diabetic macular edema and dry age-related macular degeneration. Biomed Opt Express (2017) 0.75
Lack of the P2X7 receptor protects against AMD-like defects and microparticle accumulation in a chronic oxidative stress-induced mouse model of AMD. Biochem Biophys Res Commun (2016) 0.75
Contributions of age-related alterations of the retinal pigment epithelium and of glia to the AMD-like pathology in OXYS rats. Sci Rep (2017) 0.75
Repressed SIRT1/PGC-1α pathway and mitochondrial disintegration in iPSC-derived RPE disease model of age-related macular degeneration. J Transl Med (2016) 0.75
BMP9/ALK1 inhibits neovascularization in mouse models of age-related macular degeneration. Oncotarget (2016) 0.75
Timing of Antioxidant Gene Therapy: Implications for Treating Dry AMD. Invest Ophthalmol Vis Sci (2017) 0.75
Protective responses to sublytic complement in the retinal pigment epithelium. Proc Natl Acad Sci U S A (2016) 0.75
Roles of exosomes in the normal and diseased eye. Prog Retin Eye Res (2017) 0.75
Taxifolin protects RPE cells against oxidative stress-induced apoptosis. Mol Vis (2017) 0.75
The effect of orbital implantation on peripheral blood melatonin and sex hormone levels in child patients with congenital eyeball dysplasia. Exp Ther Med (2017) 0.75
Optical coherence tomography. Science (1991) 57.87
Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol (2001) 21.37
Complement factor H variant increases the risk of age-related macular degeneration. Science (2005) 17.95
Complement factor H polymorphism and age-related macular degeneration. Science (2005) 17.79
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A (2005) 13.44
Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci (2007) 11.11
ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models. Science (2012) 10.42
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res (2001) 8.38
Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet (2006) 8.33
The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol (2000) 8.10
Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet (2002) 6.56
The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology (1997) 6.47
Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med (2007) 6.47
Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A (2002) 6.47
A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol (2002) 5.57
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA (1994) 5.43
The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 5.08
Age-related macular degeneration. N Engl J Med (2006) 5.06
Retinal degeneration mutants in the mouse. Vision Res (2002) 4.93
ApoE promotes the proteolytic degradation of Abeta. Neuron (2008) 4.75
The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol (2005) 4.46
Automatic segmentation of seven retinal layers in SDOCT images congruent with expert manual segmentation. Opt Express (2010) 4.45
Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res (2001) 4.38
Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet (2002) 4.22
The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci (2012) 4.11
Restoration of vision after transplantation of photoreceptors. Nature (2012) 3.91
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology (2002) 3.80
A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol (2005) 3.74
The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology (1993) 3.58
Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology (2004) 3.53
RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res (2005) 3.52
Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol Biol Cell (2001) 3.41
The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res (2009) 3.40
CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest (2007) 3.39
Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol (2011) 3.28
Noninvasive imaging of the human rod photoreceptor mosaic using a confocal adaptive optics scanning ophthalmoscope. Biomed Opt Express (2011) 3.21
Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci (2001) 3.19
Clinical classification of age-related macular degeneration. Ophthalmology (2013) 2.92
The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A (2002) 2.74
Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp Eye Res (2003) 2.73
Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol (1992) 2.71
Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells. Invest Ophthalmol Vis Sci (1984) 2.65
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature (2011) 2.64
A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res (2000) 2.58
Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis (2002) 2.53
The central role of the alternative complement pathway in human disease. J Immunol (2006) 2.53
Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am J Pathol (2006) 2.52
Automated identification of cone photoreceptors in adaptive optics retinal images. J Opt Soc Am A Opt Image Sci Vis (2007) 2.44
Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest Ophthalmol Vis Sci (2007) 2.36
Microglia activation in retinal degeneration. J Leukoc Biol (2007) 2.31
Histopathology of age-related macular degeneration. Mol Vis (1999) 2.27
Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group. Arch Ophthalmol (1993) 2.24
Ccl2, Cx3cr1 and Ccl2/Cx3cr1 chemokine deficiencies are not sufficient to cause age-related retinal degeneration. Exp Eye Res (2012) 2.18
The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium. Proc Natl Acad Sci U S A (2002) 2.18
Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol (1994) 2.15
Immunology of age-related macular degeneration. Nat Rev Immunol (2013) 2.14
High-resolution in vivo imaging of the RPE mosaic in eyes with retinal disease. Invest Ophthalmol Vis Sci (2007) 2.11
Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. Ophthalmology (2009) 2.07
Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina. Nat Biotechnol (2013) 2.06
The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J (2004) 2.04
Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J (1999) 2.00
Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography. Ophthalmology (2010) 1.93
Predictive value of fundus autofluorescence for development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci (2006) 1.92
Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol (1988) 1.92
Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer (2012) 1.92
Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology (2007) 1.90
Validated automatic segmentation of AMD pathology including drusen and geographic atrophy in SD-OCT images. Invest Ophthalmol Vis Sci (2012) 1.86
Autophagy and exosomes in the aged retinal pigment epithelium: possible relevance to drusen formation and age-related macular degeneration. PLoS One (2009) 1.84
Transplantation of the RPE in AMD. Prog Retin Eye Res (2007) 1.81
The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol (2010) 1.78
Regulation of the aging process by autophagy. Trends Mol Med (2009) 1.69
Therapeutic targets in age-related macular disease. J Clin Invest (2010) 1.68
Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci (2000) 1.67
Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology (2001) 1.67
Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol (1998) 1.65
Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models". Science (2013) 1.64
Prion protein amyloidosis. Brain Pathol (1996) 1.64
Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am J Ophthalmol (2001) 1.64
Adaptation of a support vector machine algorithm for segmentation and visualization of retinal structures in volumetric optical coherence tomography data sets. J Biomed Opt (2007) 1.62
Abundant lipid and protein components of drusen. PLoS One (2010) 1.62
The oil spill in ageing Bruch membrane. Br J Ophthalmol (2011) 1.62
Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci U S A (2007) 1.62
mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice. J Clin Invest (2010) 1.61
Expanded polytetrafluoroethylene as a substrate for retinal pigment epithelial cell growth and transplantation in age-related macular degeneration. Br J Ophthalmol (2011) 1.60
Consequences of oxidative stress in age-related macular degeneration. Mol Aspects Med (2012) 1.59
Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology (2007) 1.59
mTOR: on target for novel therapeutic strategies in the nervous system. Trends Mol Med (2012) 1.59
Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol (2009) 1.57
Sparsity based denoising of spectral domain optical coherence tomography images. Biomed Opt Express (2012) 1.57
Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization? Arch Ophthalmol (2004) 1.57
Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc Natl Acad Sci U S A (2011) 1.56
Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol (2006) 1.55
Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models". Science (2013) 1.54
Adaptive optics retinal imaging: emerging clinical applications. Optom Vis Sci (2010) 1.53
The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol (1989) 1.53
Automated non-rigid registration and mosaicing for robust imaging of distinct retinal capillary beds using speckle variance optical coherence tomography. Biomed Opt Express (2013) 1.50
Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models". Science (2013) 1.50
Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J (2004) 1.48
Automatic segmentation of seven retinal layers in SDOCT images congruent with expert manual segmentation. Opt Express (2010) 4.45
Imaging the infant retina with a hand-held spectral-domain optical coherence tomography device. Am J Ophthalmol (2008) 3.17
Dynamics of human foveal development after premature birth. Ophthalmology (2011) 3.11
Insights into advanced retinopathy of prematurity using handheld spectral domain optical coherence tomography imaging. Ophthalmology (2009) 2.99
Intraoperative use of handheld spectral domain optical coherence tomography imaging in macular surgery. Retina (2009) 2.97
Integration of a spectral domain optical coherence tomography system into a surgical microscope for intraoperative imaging. Invest Ophthalmol Vis Sci (2011) 2.67
Analysis of pars plana vitrectomy for optic pit-related maculopathy with intraoperative optical coherence tomography: a possible connection with the vitreous cavity. Arch Ophthalmol (2011) 2.67
Intraoperative spectral domain optical coherence tomography for vitreoretinal surgery. Opt Lett (2010) 2.52
Kernel regression for image processing and reconstruction. IEEE Trans Image Process (2007) 2.36
Correlation of pathologic features in spectral domain optical coherence tomography with conventional retinal studies. Retina (2008) 2.22
Optimizing hand-held spectral domain optical coherence tomography imaging for neonates, infants, and children. Invest Ophthalmol Vis Sci (2010) 2.11
Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. Ophthalmology (2009) 2.07
Abnormal foveal morphology in ocular albinism imaged with spectral-domain optical coherence tomography. Arch Ophthalmol (2009) 1.93
Validated automatic segmentation of AMD pathology including drusen and geographic atrophy in SD-OCT images. Invest Ophthalmol Vis Sci (2012) 1.86
Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology (2008) 1.83
Spectral domain optical coherence tomography imaging of geographic atrophy margins. Ophthalmology (2009) 1.80
Visualization of real-time intraoperative maneuvers with a microscope-mounted spectral domain optical coherence tomography system. Retina (2013) 1.78
Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmology (2012) 1.73
Preclinical evaluation and intraoperative human retinal imaging with a high-resolution microscope-integrated spectral domain optical coherence tomography device. Retina (2013) 1.68
Maturation of the human fovea: correlation of spectral-domain optical coherence tomography findings with histology. Am J Ophthalmol (2012) 1.65
Choroid development and feasibility of choroidal imaging in the preterm and term infants utilizing SD-OCT. Invest Ophthalmol Vis Sci (2013) 1.64
Sparsity based denoising of spectral domain optical coherence tomography images. Biomed Opt Express (2012) 1.57
Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials. Ophthalmology (2013) 1.57
Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc Natl Acad Sci U S A (2011) 1.56
The use of optical coherence tomography in intraoperative ophthalmic imaging. Ophthalmic Surg Lasers Imaging (2011) 1.53
Automated non-rigid registration and mosaicing for robust imaging of distinct retinal capillary beds using speckle variance optical coherence tomography. Biomed Opt Express (2013) 1.50
Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring. PLoS Pathog (2010) 1.49
Spectral-domain optical coherence tomographic assessment of severity of cystoid macular edema in retinopathy of prematurity. Arch Ophthalmol (2012) 1.43
Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration. Arch Ophthalmol (2002) 1.39
Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology (2005) 1.39
Robust automatic segmentation of corneal layer boundaries in SDOCT images using graph theory and dynamic programming. Biomed Opt Express (2011) 1.37
Macular features from spectral-domain optical coherence tomography as an adjunct to indirect ophthalmoscopy in retinopathy of prematurity. Retina (2011) 1.31
Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. JAMA Ophthalmol (2013) 1.31
Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs. Invest Ophthalmol Vis Sci (2010) 1.30
Histologic development of the human fovea from midgestation to maturity. Am J Ophthalmol (2012) 1.29
Unprocessed real-time imaging of vitreoretinal surgical maneuvers using a microscope-integrated spectral-domain optical coherence tomography system. Graefes Arch Clin Exp Ophthalmol (2012) 1.25
Enhanced video indirect ophthalmoscopy (VIO) via robust mosaicing. Biomed Opt Express (2011) 1.24
Visual outcomes following macular translocation with 360-degree peripheral retinectomy. Arch Ophthalmol (2002) 1.21
Automatic segmentation of closed-contour features in ophthalmic images using graph theory and dynamic programming. Biomed Opt Express (2012) 1.21
Correction of ocular shape in retinal optical coherence tomography and effect on current clinical measures. Am J Ophthalmol (2013) 1.19
Subfoveal fluid in healthy full-term newborns observed by handheld spectral-domain optical coherence tomography. Am J Ophthalmol (2011) 1.18
Fast acquisition and reconstruction of optical coherence tomography images via sparse representation. IEEE Trans Med Imaging (2013) 1.15
Handheld simultaneous scanning laser ophthalmoscopy and optical coherence tomography system. Biomed Opt Express (2013) 1.09
Automatic cone photoreceptor segmentation using graph theory and dynamic programming. Biomed Opt Express (2013) 1.09
Exploratory Dijkstra forest based automatic vessel segmentation: applications in video indirect ophthalmoscopy (VIO). Biomed Opt Express (2012) 1.07
Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci. Ophthalmology (2013) 1.06
Interlaced spectrally encoded confocal scanning laser ophthalmoscopy and spectral domain optical coherence tomography. Biomed Opt Express (2010) 1.06
Fully automatic software for retinal thickness in eyes with diabetic macular edema from images acquired by cirrus and spectralis systems. Invest Ophthalmol Vis Sci (2013) 1.06
Reversible retinal edema in an infant with neonatal hemochromatosis and liver failure. J AAPOS (2011) 1.05
Distributed scanning volumetric SDOCT for motion corrected corneal biometry. Biomed Opt Express (2012) 1.05
Foveal avascular zone and foveal pit formation after preterm birth. Br J Ophthalmol (2012) 1.03
Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration. Ophthalmology (2012) 1.03
Proteomic profiling of a layered tissue reveals unique glycolytic specializations of photoreceptor cells. Mol Cell Proteomics (2010) 1.01
Optical coherence tomography reader agreement in neovascular age-related macular degeneration. Am J Ophthalmol (2007) 1.00
Age-related changes in vitreous mobility as measured by video B scan ultrasound. Exp Eye Res (2002) 0.98
Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration. Ophthalmology (2005) 0.97
Recurrence of retinal pigment epithelial changes after macular translocation with 360 degrees peripheral retinectomy for geographic atrophy. Arch Ophthalmol (2005) 0.95
Image inversion spectral-domain optical coherence tomography optimizes choroidal thickness and detail through improved contrast. Invest Ophthalmol Vis Sci (2012) 0.95
Clinicopathologic studies of eyes that were obtained postmortem from four patients who were enrolled in the submacular surgery trials: SST Report No. 16. Am J Ophthalmol (2006) 0.95
Efficient fourier-wavelet super-resolution. IEEE Trans Image Process (2010) 0.95
Coherence revival multiplexed, buffered swept source optical coherence tomography: 400 kHz imaging with a 100 kHz source. Opt Lett (2014) 0.95
Spatial correlation between hyperpigmentary changes on color fundus photography and hyperreflective foci on SDOCT in intermediate AMD. Invest Ophthalmol Vis Sci (2012) 0.94
Evaluation of contrast agents for enhanced visualization in optical coherence tomography. Invest Ophthalmol Vis Sci (2010) 0.94
Corneal biometry from volumetric SDOCT and comparison with existing clinical modalities. Biomed Opt Express (2012) 0.94
Developing SDOCT to assess donor human eyes prior to tissue sectioning for research. Graefes Arch Clin Exp Ophthalmol (2009) 0.94
Spectral domain optical coherence tomography characterization of pediatric epiretinal membranes. Retina (2014) 0.92
Dislocation of the donor graft to the posterior segment in descemet stripping automated endothelial keratoplasty. Am J Ophthalmol (2011) 0.92
Recurrent choroidal neovascularization after macular translocation surgery with 360-degree peripheral retinectomy. Retina (2008) 0.91
Optical coherence tomography in retinopathy of prematurity: looking beyond the vessels. Clin Perinatol (2013) 0.90
Real-Time Microscope-Integrated OCT to Improve Visualization in DSAEK for Advanced Bullous Keratopathy. Cornea (2015) 0.90
Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration. Ophthalmology (2004) 0.90
Proteolytic cleavage and shedding of the bovine prion protein in two cell culture systems. Virus Res (2005) 0.89
Characterization of vitreoretinal interface disorders using OCT in the interventional phase 3 trials of ocriplasmin. Invest Ophthalmol Vis Sci (2012) 0.89